Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles

References

• Apostolopoulos V, Barnes N, Pietersz GA, McKenzie IF. 2000. Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses. Vaccine 18(27):3174–84.
   PubMed Web of Science ®Google Scholar
• Apostolopoulos V, Pietersz GA, Tsibanis A, Tsikkinis A, Drakaki H, Loveland BE, Piddlesden SJ, Plebanski M, Pouniotis DS, Alexis MN and others. 2006. Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]. Breast Cancer Res 8(3):R27.
   PubMedGoogle Scholar
• Budhian A, Siegel SJ, Winey KI. 2005. Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol. J Microencapsul 22(7):773–85.
   PubMed Web of Science ®Google Scholar
• Cai C, Mao S, Germershaus O, Schaper A, Rytting E, Chen D, Kissel T. 2008. Influence of morphology and drug distribution on the release process of FITC-dextran-loaded microspheres prepared with different types of PLGA. J Microencapsul:1–12.
   PubMedGoogle Scholar
• Cambi A, Netea MG, Mora-Montes HM, Gow NA, Hato SV, Lowman DW, Kullberg BJ, Torensma R, Williams DL, Figdor CG. 2008. Dendritic cell interaction with Candida albicans critically depends on N-linked mannan. J Biol Chem 283(29):20590–9.
   PubMed Web of Science ®Google Scholar
• Clawson C, Huang CT, Futalan D, Martin Seible D, Saenz R, Larsson M, Ma W, Minev B, Zhang F, Ozkan M and others. 2010. Delivery of a peptide via poly(d,l-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell-stimulatory capacity. Nanomedicine.
   PubMed Web of Science ®Google Scholar
• Diwan M, Elamanchili P, Lane H, Gainer A, Samuel J. 2003. Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses. J Drug Target 11(8-10):495–507.
   PubMed Web of Science ®Google Scholar
• Elamanchili P, Diwan M, Cao M, Samuel J. 2004. Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine 22(19):2406–12.
   PubMed Web of Science ®Google Scholar
• Elamanchili P, Lutsiak CM, Hamdy S, Diwan M, Samuel J. 2007. “Pathogen-mimicking” nanoparticles for vaccine delivery to dendritic cells. J Immunother 30(4):378–95.
   PubMed Web of Science ®Google Scholar
• Engering AJ, Cella M, Fluitsma D, Brockhaus M, Hoefsmit EC, Lanzavecchia A, Pieters J. 1997. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur J Immunol 27(9):2417–25.
   PubMed Web of Science ®Google Scholar
• Espuelas S, Thumann C, Heurtault B, Schuber F, Frisch B. 2008. Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes. Bioconjug Chem 19(12):2385–93.
   PubMed Web of Science ®Google Scholar
• Ezekowitz RA, Sastry K, Bailly P, Warner A. 1990. Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J Exp Med 172(6):1785–94.
   PubMed Web of Science ®Google Scholar
• Figdor CG, van Kooyk Y, Adema GJ. 2002. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2(2):77–84.
   PubMed Web of Science ®Google Scholar
• Fischer S, Schlosser E, Mueller M, Csaba N, Merkle HP, Groettrup M, Gander B. 2009. Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response. J Drug Target.
   PubMed Web of Science ®Google Scholar
• Foged C, Brodin B, Frokjaer S, Sundblad A. 2005. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 298(2):315–22.
   PubMedGoogle Scholar
• Haddadi A, Elamanchili P, Lavasanifar A, Das S, Shapiro J, Samuel J. 2008. Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells. J Biomed Mater Res A 84(4):885–98.
   PubMedGoogle Scholar
• Hamdy S, Elamanchili P, Alshamsan A, Molavi O, Satou T, Samuel J. 2007. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles. J Biomed Mater Res A 81(3):652–62.
   PubMedGoogle Scholar
• Hamdy S, Molavi O, Ma Z, Haddadi A, Alshamsan A, Gobti Z, Elhasi S, Samuel J, Lavasanifar A. 2008. Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity. Vaccine 26(39):5046–57.
   PubMed Web of Science ®Google Scholar
• Jain S, Vyas SP. 2006. Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization. J Liposome Res 16(4):331–45.
   PubMed Web of Science ®Google Scholar
• Jaklenec A, Hinckfuss A, Bilgen B, Ciombor DM, Aaron R, Mathiowitz E. 2008. Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds. Biomaterials 29(10):1518–25.
   PubMed Web of Science ®Google Scholar
• Jiang HL, Kang ML, Quan JS, Kang SG, Akaike T, Yoo HS, Cho CS. 2008. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization. Biomaterials 29(12):1931–9.
   PubMed Web of Science ®Google Scholar
• Joralemon MJ, Murthy KS, Remsen EE, Becker ML, Wooley KL. 2004. Synthesis, characterization, and bioavailability of mannosylated shell cross-linked nanoparticles. Biomacromolecules 5(3):903–13.
   PubMed Web of Science ®Google Scholar
• Kel J, Oldenampsen J, Luca M, Drijfhout JW, Koning F, Nagelkerken L. 2007. Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis. Am J Pathol 170(1):272–80.
   PubMed Web of Science ®Google Scholar
• Keler T, Ramakrishna V, Fanger MW. 2004. Mannose receptor-targeted vaccines. Expert Opin Biol Ther 4(12):1953–62.
   PubMed Web of Science ®Google Scholar
• Kempf M, Mandal B, Jilek S, Thiele L, Voros J, Textor M, Merkle HP, Walter E. 2003. Improved stimulation of human dendritic cells by receptor engagement with surface-modified microparticles. J Drug Target 11(1):11–8.
   PubMed Web of Science ®Google Scholar
• Lam JS, Mansour MK, Specht CA, Levitz SM. 2005. A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. J Immunol 175(11):7496–503.
   PubMed Web of Science ®Google Scholar
• Lutsiak ME, Kwon GS, Samuel J. 2006. Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses. J Pharm Pharmacol 58(6):739–47.
   PubMed Web of Science ®Google Scholar
• Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223(1):77–92.
   PubMed Web of Science ®Google Scholar
• Masuko T, Minami A, Iwasaki N, Majima T, Nishimura S, Lee YC. 2005. Carbohydrate analysis by a phenol-sulfuric acid method in microplate format. Anal Biochem 339(1):69–72.
   PubMed Web of Science ®Google Scholar
• McKenzie EJ, Taylor PR, Stillion RJ, Lucas AD, Harris J, Gordon S, Martinez-Pomares L. 2007. Mannose receptor expression and function define a new population of murine dendritic cells. J Immunol 178(8):4975–83.
   PubMed Web of Science ®Google Scholar
• Presicce P, Taddeo A, Conti A, Villa ML, Della Bella S. 2008. Keyhole limpet hemocyanin induces the activation and maturation of human dendritic cells through the involvement of mannose receptor. Mol Immunol 45(4):1136–45.
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Yang JC, Restifo NP. 2004. Cancer immunotherapy: moving beyond current vaccines. Nat Med 10(9):909–15.
   PubMed Web of Science ®Google Scholar
• Schlosser E, Mueller M, Fischer S, Basta S, Busch DH, Gander B, Groettrup M. 2008. TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine 26(13):1626–37.
   PubMed Web of Science ®Google Scholar
• Schuster M, Nechansky A, Kircheis R. 2006. Cancer immunotherapy. Biotechnol J 1(2):138–47.
   Google Scholar
• Sheng KC, Kalkanidis M, Pouniotis DS, Esparon S, Tang CK, Apostolopoulos V, Pietersz GA. 2008. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo. Eur J Immunol 38(2):424–36.
   PubMed Web of Science ®Google Scholar
• Sheng KC, Pouniotis DS, Wright MD, Tang CK, Lazoura E, Pietersz GA, Apostolopoulos V. 2006. Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells. Immunology 118(3):372–83.
   PubMed Web of Science ®Google Scholar
• Stahl PD, Ezekowitz RA. 1998. The mannose receptor is a pattern recognition receptor involved in host defense. Curr Opin Immunol 10(1):50–5.
   PubMed Web of Science ®Google Scholar
• Ueda M, Kreuter J. 1997. Optimization of the preparation of loperamide-loaded poly (L-lactide) nanoparticles by high pressure emulsification-solvent evaporation. J Microencapsul 14(5):593–605.
   PubMed Web of Science ®Google Scholar
• van Kooyk Y. 2008. C-type lectins on dendritic cells: key modulators for the induction of immune responses. Biochem Soc Trans 36(Pt 6):1478–81.
   PubMedGoogle Scholar
• Vinogradov E, Petersen B, Bock K. 1998. Structural analysis of the intact polysaccharide mannan from Saccharomyces cerevisiae yeast using 1H and 13C NMR spectroscopy at 750 MHz. Carbohydr Res 307(1-2):177–83.
   PubMed Web of Science ®Google Scholar
• Wattendorf U, Coullerez G, Voros J, Textor M, Merkle HP. 2008. Mannose-based molecular patterns on stealth microspheres for receptor-specific targeting of human antigen-presenting cells. Langmuir 24(20):11790–802.
   PubMed Web of Science ®Google Scholar
• Wei H, Wang S, Zhang D, Hou S, Qian W, Li B, Guo H, Kou G, He J, Wang H and others. 2009. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice. Clin Cancer Res 15(14):4612–21.
   PubMed Web of Science ®Google Scholar
• White KL, Rades T, Furneaux RH, Tyler PC, Hook S. 2006. Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells. J Pharm Pharmacol 58(6):729–37.
   PubMed Web of Science ®Google Scholar
• Xiang SD, Scholzen A, Minigo G, David C, Apostolopoulos V, Mottram PL, Plebanski M. 2006. Pathogen recognition and development of particulate vaccines: does size matter? Methods 40(1):1–9.
   PubMed Web of Science ®Google Scholar
• Zelensky AN, Gready JE. 2005. The C-type lectin-like domain superfamily. Febs J 272(24):6179–217.
   PubMed Web of Science ®Google Scholar